As of 2024-07-27, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 42.25 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.72 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 638.6%.
The range of the Relative Valuation is 25.90 - 58.36 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.8x - 31.8x | 31.3x |
| Forward P/E multiples | 26.7x - 30.3x | 28.8x |
| Fair Price | 25.90 - 58.36 | 42.25 |
| Upside | 352.7% - 920.3% | 638.6% |
| Date | P/E |
| 2024-07-26 | 6.14 |
| 2024-07-25 | 6.16 |
| 2024-07-24 | 5.78 |
| 2024-07-23 | 6.19 |
| 2024-07-22 | 6.22 |
| 2024-07-19 | 6.30 |
| 2024-07-18 | 6.18 |
| 2024-07-17 | 6.42 |
| 2024-07-16 | 6.45 |
| 2024-07-15 | 6.41 |
| 2024-07-12 | 6.46 |
| 2024-07-11 | 6.47 |
| 2024-07-10 | 6.48 |
| 2024-07-09 | 6.52 |
| 2024-07-08 | 6.45 |
| 2024-07-05 | 5.90 |
| 2024-07-03 | 5.90 |
| 2024-07-02 | 5.61 |
| 2024-07-01 | 5.94 |
| 2024-06-28 | 6.01 |
| 2024-06-27 | 5.39 |
| 2024-06-26 | 5.28 |
| 2024-06-25 | 4.88 |
| 2024-06-24 | 4.81 |
| 2024-06-21 | 4.44 |
| 2024-06-20 | 4.37 |
| 2024-06-18 | 4.24 |
| 2024-06-17 | 4.36 |
| 2024-06-14 | 4.13 |
| 2024-06-13 | 4.10 |
| 2024-06-12 | 3.94 |
| 2024-06-11 | 3.95 |
| 2024-06-10 | 3.82 |
| 2024-06-07 | 3.98 |
| 2024-06-06 | 4.00 |
| 2024-06-05 | 4.29 |
| 2024-06-04 | 3.80 |
| 2024-06-03 | 4.09 |
| 2024-05-31 | 3.73 |
| 2024-05-30 | 3.68 |
| 2024-05-29 | 3.59 |
| 2024-05-28 | 4.21 |
| 2024-05-24 | 4.02 |
| 2024-05-23 | 4.00 |
| 2024-05-22 | 4.09 |
| 2024-05-21 | 4.69 |
| 2024-05-20 | 4.95 |
| 2024-05-17 | 5.11 |
| 2024-05-16 | 5.10 |
| 2024-05-15 | 4.95 |